Fuse Medical (OTC: FZMD) has completed its acquisition of Maxim Surgical, a spinal fusion device company and device distributor, for an undisclosed sum.
It’s the second acquisition in the past year for Fuse, which purchased CPM Medical Consultants in December 2017. All three companies are based in Richardson, Texas.
Formed in April 2011, Maxim designs and manufactures spinal interbody spacers and distributes a variety of spine, sports medicine, and biologics product lines. Its portfolio of spinal implant products includes the FDA-cleared X-Treme Interbody Fusion System. Maxim’s long-term strategy is to bring more innovative spinal implant products to market for retail and wholesale distribution.
“We are very excited that Maxim has become part of the Fuse family,” Fuse CEO Christopher Reeg said in a prepared statement. “Maxim’s portfolio of products bolsters our strategy of expanding Fuse into medical device design and manufacturing.
“We believe that integrating Maxim with our operations will enhance Fuse’s earnings immediately and allow us to be even better positioned to meet our customers’ needs,” Reeg added.
Fuse provides a broad portfolio of orthopedic implants including internal and external fixation products; upper and lower extremity plating; total joint reconstruction; soft tissue fixation and augmentation for sports medicine procedures; full spinal implants for trauma, degenerative disc disease, and deformity indications. Its biologics offerings include human allografts, substitute bone materials and tendons, as well as regenerative tissues and fluids to augment orthopedic surgeries.
